Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials.
van der Heijde D, Deodhar A, Baraliakos X, Brown MA, Dobashi H, Dougados M, Elewaut D, Ellis AM, Fleurinck C, Gaffney K, Gensler LS, Haroon N, Magrey M, Maksymowych WP, Marten A, Massow U, Oortgiesen M, Poddubnyy D, Rudwaleit M, Shepherd-Smith J, Tomita T, Van den Bosch F, Vaux T, Xu H. van der Heijde D, et al. Among authors: marten a. Ann Rheum Dis. 2023 Apr;82(4):515-526. doi: 10.1136/ard-2022-223595. Epub 2023 Jan 17. Ann Rheum Dis. 2023. PMID: 36649967 Free PMC article.
Bimekizumab treatment in patients with active axial spondyloarthritis: 52-week efficacy and safety from the randomised parallel phase 3 BE MOBILE 1 and BE MOBILE 2 studies.
Baraliakos X, Deodhar A, van der Heijde D, Magrey M, Maksymowych WP, Tomita T, Xu H, Massow U, Fleurinck C, Ellis AM, Vaux T, Shepherd-Smith J, Marten A, Gensler LS. Baraliakos X, et al. Among authors: marten a. Ann Rheum Dis. 2024 Jan 11;83(2):199-213. doi: 10.1136/ard-2023-224803. Ann Rheum Dis. 2024. PMID: 37793792 Free article. Clinical Trial.
Long-Term Safety and Efficacy of Bimekizumab in Axial Spondyloarthritis: 2-Year Results from Two Phase 3 Studies.
Baraliakos X, Deodhar A, van der Heijde D, Van den Bosch F, Magrey M, Maksymowych WP, Tomita T, Xu H, Massow U, Vaux T, Prajapati C, Manente M, Marten A, Gensler LS. Baraliakos X, et al. Among authors: marten a. Rheumatology (Oxford). 2025 Jan 11:keaf009. doi: 10.1093/rheumatology/keaf009. Online ahead of print. Rheumatology (Oxford). 2025. PMID: 39798135
The association of increased pre- and postnatal NO2 and PM2.5 exposure with the infant nasal microbiome composition and respiratory symptoms.
Künstle N, Gorlanova O, Rüttimann C, Mostacci N, Röösli M, de Hoogh K, Flückiger B, Da Silva Sena CR, Steinberg R, Korten I, Yammine S, Schulzke S, Latzin P, Hilty M, Frey U; BILD study group. Künstle N, et al. Environ Res. 2024 Dec 24;267:120694. doi: 10.1016/j.envres.2024.120694. Online ahead of print. Environ Res. 2024. PMID: 39725140 Free article.
Effects of land cover and protected areas on flying insect diversity.
Sinclair JS, Buchner D, Gessner MO, Müller J, Pauls SU, Stoll S, Welti EAR, Bässler C, Buse J, Dziock F, Enss J, Hörren T, Künast R, Li Y, Marten A, Morkel C, Richter R, Seibold S, Sorg M, Twietmeyer S, Weis D, Weisser W, Wiggering B, Wilmking M, Zotz G, Frenzel M, Leese F, Haase P. Sinclair JS, et al. Among authors: marten a. Conserv Biol. 2024 Dec 4:e14425. doi: 10.1111/cobi.14425. Online ahead of print. Conserv Biol. 2024. PMID: 39628456
Comparison of nasal microbiota between preterm and full-term infants in early life.
Gorlanova O, Nissen-Kratzert A, Mostacci N, Rüttimann C, Künstle N, Marten A, Gisler A, Bacher K, Decrue F, Salem Y, Usemann J, Korten I, Yammine S, Nahum U, Schulzke S, Latzin P, Röösli M, Fuchs O; BILD study consortium; Hilty M, Frey U. Gorlanova O, et al. Among authors: marten a. Pediatr Res. 2024 Nov 30. doi: 10.1038/s41390-024-03675-6. Online ahead of print. Pediatr Res. 2024. PMID: 39616239
139 results